Memory Disorders Research Group, Department of Neurology, Rigshospitalet, Copenhagen University Hospital , Copenhagen , Denmark .
Biomarkers. 2014 Jun;19(4):259-68. doi: 10.3109/1354750X.2014.904001. Epub 2014 Mar 29.
MicroRNAs (miRNA) are biological molecules transcribed from non-protein coding regions of the genome, participating in regulating cellular processes. MiRNAs in biofluids may possess neurodegenerative disease biomarker potential for screening tests, differential diagnosis and disease progression monitoring. This systematic review clarifies biomarker potential of miRNAs detected in biofluids of neurodegenerative disease patients. Thirty-three and ten miRNAs displayed significant expression between patients with multiple sclerosis and Alzheimer's disease, respectively, compared to healthy controls in minimum two studies. Thirty-eight miRNAs showed biomarker potential by distinguishing significantly between minimum two diseases. Summarized data directs future research towards discovering new biomarkers for neurodegenerative diseases.
微小 RNA(miRNA)是从基因组的非蛋白编码区转录而来的生物分子,参与调节细胞过程。体液中的 miRNA 可能具有神经退行性疾病筛查试验、鉴别诊断和疾病进展监测的生物标志物潜力。本系统评价阐明了在神经退行性疾病患者的生物体液中检测到的 miRNA 的生物标志物潜力。与健康对照组相比,在至少两项研究中,多发性硬化症和阿尔茨海默病患者的 33 种和 10 种 miRNA 分别显示出显著的表达差异。38 种 miRNA 通过在至少两种疾病之间的显著区分显示出生物标志物潜力。总结的数据为发现神经退行性疾病的新生物标志物指明了未来的研究方向。